October 12, 2021
Skye is limitless
Unlocking the pharmaceutical potential of cannabinoids
We are a pharmaceutical company developing proprietary cannabinoid derivatives to treat glaucoma and other diseases
Our focus is on applying the well-established rigor of pharmaceutical drug development to a new class of therapeutics that target diseases in a safe and effective manner.